Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Marvell Asks Shareholders To Reject TRC Capital's Mini-Tender Offer

RELATED NEWS
Trade MRVL now with 
3/26/2012 8:13 AM ET

Marvell Technology Group Ltd. (MRVL: Quote) Monday said it did not endorse a mini-tender offer by TRC Capital Corp., and asked that shareholders not tender their shares in the offer. TRC Capital sought to purchase up to 6 million shares at $15 per share, Marvell added.

The offer price, Marvell elaborated, was 4.94 percent lower than the closing price on March 22, 2012, the date of the offer's commencement. Marvell also noted that TRC Capital had earlier made similar offers for other companies' shares.

Click here to receive FREE breaking news email alerts for Marvell Technology Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Russian Foreign Minister Sergei Lavrov warned Wednesday that Moscow would retaliate strongly if its "interests" in Ukraine are attacked. He also criticized the Ukrainian administration for relaunching its so-called anti-terrorist operation in the east of the country a day earlier. Lavrov's remarks came in an interview with Russia Today, which published excerpts of the English-language interview to While selling pressure has remained relatively subdued, stocks continue to see modest weakness in mid-day trading on Wednesday. The losses on the day come on the heels of the upward trend seen over the past several sessions. The major averages have moved roughly sideways in recent trading, lingering in the red. While a majority of Kentucky voters approve of the way Rand Paul is handling his job as Senator, the results of New York Times/Kaiser Family Foundation poll showed that voters from the Bluegrass State have a more mixed view on Paul's potential run for president in 2016.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.